U.S. Markets close in 6 hrs 18 mins

Investors Who Bought Reliq Health Technologies (CVE:RHT) Shares Three Years Ago Are Now Up 410%

Simply Wall St

Reliq Health Technologies Inc. (CVE:RHT) shareholders might be concerned after seeing the share price drop 11% in the last month. But that doesn't displace its brilliant performance over three years. In fact, the share price has taken off in that time, up 410%. As long term investors the recent fall doesn't detract all that much from the longer term story. The share price action could signify that the business itself is dramatically improved, in that time.

See our latest analysis for Reliq Health Technologies

Reliq Health Technologies recorded just CA$455,265 in revenue over the last twelve months, which isn't really enough for us to consider it to have a proven product. So it seems that the investors focused more on what could be, than paying attention to the current revenues (or lack thereof). It seems likely some shareholders believe that Reliq Health Technologies will significantly advance the business plan before too long.

As a general rule, if a company doesn't have much revenue, and it loses money, then it is a high risk investment. You should be aware that there is always a chance that this sort of company will need to issue more shares to raise money to continue pursuing its business plan. While some such companies do very well over the long term, others become hyped up by promoters before eventually falling back down to earth, and going bankrupt (or being recapitalized). Reliq Health Technologies has already given some investors a taste of the sweet gains that high risk investing can generate, if your timing is right.

Our data indicates that Reliq Health Technologies had CA$1.1m more in total liabilities than it had cash, when it last reported in September 2019. That makes it extremely high risk, in our view. So we're surprised to see the stock up 49% per year, over 3 years , but we're happy for holders. Investors must really like its potential. The image below shows how Reliq Health Technologies's balance sheet has changed over time; if you want to see the precise values, simply click on the image. You can see in the image below, how Reliq Health Technologies's cash levels have changed over time (click to see the values).

TSXV:RHT Historical Debt, December 12th 2019

It can be extremely risky to invest in a company that doesn't even have revenue. There's no way to know its value easily. However you can take a look at whether insiders have been buying up shares. It's usually a positive if they have, as it may indicate they see value in the stock. Luckily we are in a position to provide you with this free chart of insider buying (and selling).

A Different Perspective

Pleasingly, Reliq Health Technologies's total shareholder return last year was 100%. That gain actually surpasses the 72% TSR it generated (per year) over three years. Given the track record of solid returns over varying time frames, it might be worth putting Reliq Health Technologies on your watchlist. If you would like to research Reliq Health Technologies in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

  • Americans to Inherit $764 Billion This Year, Mostly Tax-Free
    Business
    Bloomberg

    Americans to Inherit $764 Billion This Year, Mostly Tax-Free

    Americans are projected to inherit $764 billion this year and will pay an average tax of just 2.1% on that income, New York University law professor Lily Batchelder estimates in a paper published Tuesday by the Brookings Institution. “If anything, we should be taxing income from inheritances at higher rates than income from work,” Batchelder, a former adviser to President Barack Obama who has advised several Democratic presidential campaigns on tax policy, said in a phone interview.

  • Business
    Benzinga

    Mackenzie Bezos Gets Rid Of About $370M Of Her Amazon Shares

    An end of the year filing with the United States Securities and Exchange Commission by Jeff Bezos showed that he now exercises sole voting authority on about 19.49 million additional shares. This is about 202,000 less than the 19.7 million shares awarded to Mackenzie Bezos as part of the couple's divorce settlement in April last year, over which the e-commerce giant's founder had retained exclusive voting rights. The shares are valued at around $370 million at Amazon's after-hours price of $1831.50 on Monday.

  • The main reason for the stock market’s decline is NOT the coronavirus
    Business
    MarketWatch

    The main reason for the stock market’s decline is NOT the coronavirus

    The coronavirus is getting a bum rap as the cause of the stock market's recent weakness. That decline gathered steam on Monday, when the Dow Jones Industrial Average (DJIA) was at one point down more than 500 points. It's not that any of us should have sympathy for the virus, of course.

  • A-list celebrities attend lavish party at Jeff Bezos' D.C. home
    Politics
    Yahoo Finance Video

    A-list celebrities attend lavish party at Jeff Bezos' D.C. home

    Jeff Bezos threw a lavish party at his new Washington, D.C. home, and some high-profile names were in attendance. These include Federal Reserve chairman Jerome Powell, Ben Stiller, Kellyanne Conway, Bill Gates, and Jared and Ivanka Trump.

  • Acceleron stock soars on lung drug trial data
    Business
    American City Business Journals

    Acceleron stock soars on lung drug trial data

    Mere months after its first product was approved by the FDA, Cambridge's Acceleron Pharma is closer to executing a one-two punch after announcing new clinical trial data this week. Acceleron (Nasdaq: XLRN) reported Monday that its high blood pressure disorder drug sotatercept succeeded in a midstage trial. The rare-disease drug is designed to treat pulmonary arterial hypertension, a condition that causes the small arteries in the lungs to narrow, blocking blood flow and causing pressure to build up.

  • World
    TheStreet.com

    Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

    The selling was so intense in that period that it didn't matter if you were buying Verizon or Caterpillar or American Electric Power . There were so many people who left Wuhan, the epicenter, when they were still healthy and they are now coming down with the illness. It's pretty clear that the virus spreads from rapidly person to person, so rapidly that we are hearing lots of conspiracies about a bio lab in Wuhan that might have mistakenly discharged the coronavirus and it was not transmitted initially by animals to humans.

  • CNBC’s Jim Cramer: Here comes the panic, but don’t rush to buy the dip
    Business
    MarketWatch

    CNBC’s Jim Cramer: Here comes the panic, but don’t rush to buy the dip

    That's how CNBC host Jim Cramer described Monday's sharp selloff in the stock market, which is shaping up to be the worst we've seen in several months amid mounting fears of the spread of the coronavirus. So is it time for a little bottom-fishing ahead of a very crowded docket of earnings report in the coming days? We've been saying over and over if we get an exogenous event that's when you get the sell off, that's when you have to buy,” Cramer explained.

  • What to know for year two of the Trump tax plan
    Business
    Associated Press

    What to know for year two of the Trump tax plan

    Last year's filing season was an adjustment for taxpayers and industry professionals alike as it was the first under a massive overhaul of federal tax law. While this year's season is expected to be more sedate, there are a few tweaks to be aware of. STANDARD DEDUCTION The standard deduction doubled under the new tax law that took effect in 2018.

  • 3M will cut 1,500 jobs, misses profit target
    Business
    American City Business Journals

    3M will cut 1,500 jobs, misses profit target

    3M Co. reported lower-than-expected earnings for the fourth quarter and announced it will cut 1,500 jobs as it changes how it manages overseas operations. The cuts, which the Maplewood, Minn.-based company said would come from across "all business groups, functions and geographies," are expected to save 3M (NYSE: MMM) $110 million to $120 million a year, with as much as $50 million of that coming in 2020. 3M, which employs 96,000 people, took a restructuring charge of $134 million in the fourth quarter related to the move.

  • Harley-Davidson's shares tumble on steeper fall in revenues
    Business
    Reuters

    Harley-Davidson's shares tumble on steeper fall in revenues

    Harley-Davidson Inc on Tuesday reported a larger-than-expected decline in its motorcycles revenue, hurt by a continuing slide in retail sales in the United States, sending its shares plunging in pre-market trade. The company said revenues at its motorcycles, parts & accessories and general merchandise segment fell 8.5% to $874.1 million in the fourth quarter from a year ago. Harley's challenges in the United States, which accounts for more than half of sales, are well documented - core customers are growing older and efforts to attract new and young riders have yet to show results.

  • Business
    Barrons.com

    Pfizer Stock Is Dropping Because Its Earnings Missed Expectations

    (PFE) stock was falling in premarket trading on Tuesday after the company reported fourth quarter earnings that missed Wall Street expectations. Pfizer (ticker: PFE) reported earnings per share for the fourth quarter of 2019 of $0.55, short of the $0.58 expected by Wall Street analysts, according to FactSet. The company also released guidance for 2020, saying it expected revenues of between $48.5 billion and $50.5 billion, a calculation that includes revenues from its Upjohn division, which it plans to spin off this year.

  • AbbVie Is Nearing Takeover Of Allergan — Is It Time To Add AbbVie Stock?
    Business
    Investor's Business Daily

    AbbVie Is Nearing Takeover Of Allergan — Is It Time To Add AbbVie Stock?

    AbbVie stock ended 2019 on a high note — rocketing about 40% from its low point in August as investors re-evaluated the $63 billion plan to buy Botox-maker Allergan. The takeover deal certainly helps AbbVie diversify away from Humira, a blockbuster drug that treats inflammatory conditions. Humira already faces biosimilar rivals in Europe, and will lose patent protection in the U.S. in 2023.

  • Business
    Barrons.com

    Apple Reports Earnings Today. Here’s What To Expect.

    Also keep a close eye on guidance for the fiscal second quarter ending March: Consensus estimates for revenue and earnings per share are currently $62.5 billion and $2.82, respectively, but a growing chorus of Wall Street analysts contend the current view is too conservative. The huge runup in Apple stock has been driven by a few specific factors: Better-than-expected sales of iPhone 11; soaring demand for AirPods (the New York Times just published a length first-person account in the news section of what to do if you drop one of your AirPods into a subway grate); growing expectations for the company's services business; extreme optimism about the prospects for the first generation of 5G iPh...

  • Typical Retirement Savings By Age Groups: Are Yours Bigger?
    Business
    Investor's Business Daily

    Typical Retirement Savings By Age Groups: Are Yours Bigger?

    Active savers — in this case, Americans who own an IRA and-or a 401(k) account in the custody of Fidelity Investments — had savings for retirement of $215,400 as of Sept. according to new data IBD has obtained from Fidelity. In contrast, the average for all working-age families is shockingly low.

  • Video shows minutes after Kobe Bryant crash
    News
    Associated Press Videos

    Video shows minutes after Kobe Bryant crash

    NBA legend Kobe Bryant, his 13-year-old daughter and seven others are dead after their helicopter went down in Southern California. Jan.

  • Business
    Barrons.com

    Beyond Meat Stock Is Dropping, Pfizer Is Falling, and the Dow Is Trying to Rally

    U.S. stocks look set for a higher open even as the coronavirus outbreak in China remains the dominant factor influencing trading behavior Tuesday morning. Asian stock fell again, but European shares are higher. Hong Kong's Hang Seng Index and China's Shanghai Composite Index remain closed for Lunar New Year.

  • Business
    Bloomberg

    Elon’s Encore: Predicting the Surprises Tesla Has in Store Next

    Musk also reported being ahead of schedule opening a China plant and bringing out the Model Y crossover, kicking off a rally that's been buoyed since then by record deliveries. Tesla will have to clear a higher bar this time. Analysts are expecting an adjusted profit of $1.78 a share for the fourth quarter, a little short of what the company earned both in the prior three months and year-ago period.

  • Dow Jones Today, Stocks Bounce As Apple, AMD Rise Before Earnings; Tesla, China Stocks Rally
    Business
    Investor's Business Daily

    Dow Jones Today, Stocks Bounce As Apple, AMD Rise Before Earnings; Tesla, China Stocks Rally

    Stock futures set sights on a rebound Tuesday, as investors bought on Monday's dip and the Dow looked to snap a five-day losing streak. Investors moved into leading names, including Apple and Advanced Micro Devices ahead of their late-day earnings reports. China stocks bounced, with JD.com staking an early lead.

  • Business
    MarketWatch

    3M's stock falls after profit misses expectations, 1,500 job cuts announced

    Shares of 3M Co. (mmm) fell 1.5% in premarket trading Tuesday, after the consumer and industrial products reported a fourth-quarter profit that missed expectations while revenue matched, and said it was cutting 1,500 jobs as part of a restructuring. The company, which brands include Scotch tape and Post-it notes, said net income fell to $969 million, or $1.66 a share, from $1.35 billion, or $2.27 a share, in the year-ago period. The company said it was implementing a restructuring aimed at annual savings of $110 million to $120 million, with the job cuts, which represent about 1.6% of the global workforce, coming from all of the company's business groups and geographies.

  • Business
    MarketWatch

    Pfizer's stock falls after profit misses expectations, while revenue was in line

    Shares of Pfizer Inc. pfe) fell 0.9% in premarket trading Tuesday, after the drug maker reported a fourth-quarter profit that missed expectations, while revenue rose in line with forecasts. The company reported a net loss that narrowed to $337 million, or 6 cents a share, from $394 million, or 7 cents a share, in the year-ago period.

  • Stock market news live: Stocks futures recover slightly after worst day since October
    Business
    Yahoo Finance

    Stock market news live: Stocks futures recover slightly after worst day since October

    Global equities were up slightly Tuesday morning, steadying after fears over the deadly coronavirus in China sent the S&P 500 to its worst one-day drop since October on Monday 9:14 a.m. ET: Harley-Davidson, Dow-component 3M deliver disappointing earnings results 3M (MMM) posted fourth-quarter earnings per share and full-year profit guidance that missed consensus expectations, as the manufacturing conglomerate grappled with declining sales in its home market and in Asia. Fourth-quarter adjusted earnings per share were $1.95, or 15 cents short of consensus expectations, according to Bloomberg data.

  • Business
    MarketWatch

    Delphi Tech shares soar 53% premarket after $3.3 billion BorgWarner takeover

    Shares of Delphi Technologies Plc (dlph) soared 53% in premarket trade Tuesday, after BorgWarner Inc. (bwa) said it's acquiring the company in all-stock deal with an enterprise value of about $3.3 billion. BorgWarner, which makes technology for combustion, hybrid and electric vehicles, said Delphi shareholders will receive 0.4534 shares of its stock for each Delphi share owned. Upon closing, BorgWarner shareholders will own about 84% of the combined company, with Delphi shareholders owning the remaining 16%.

  • Apple's most exciting market is your ear: Morning Brief
    Business
    Yahoo Finance

    Apple's most exciting market is your ear: Morning Brief

    Wall Street expects holiday-quarter earnings per share to hit $4.56 on revenue of $88.38 billion. Revenue from Apple's closely-watched services segment should be right around $13 billion, according to estimates from Bloomberg. And while the Street continues chasing Apple shares higher and pronouncements about the next iPhone “supercycle” creep back into the conversation, the most compelling part of Apple's holiday quarter and the year ahead is in your ear.

  • Harley-Davidson Plunges After Missing Estimates
    Business
    Bloomberg

    Harley-Davidson Plunges After Missing Estimates

    Motorcycle revenue and shipments fell more than expected, dragging Harley's stock to the lowest levels since September in early Tuesday trading. Harley's Chief Executive Officer Matt Levatich is trying to attract new and younger riders to stanch the bleeding in the U.S., its biggest source of sales, while also making cheaper, lighter bikes to tap into demand in emerging markets. Investment in new products like electric motorcycles and middle-weight models is pressuring margins as sales continue to slide.

  • Apple Q1 earnings will put its China rebound in focus
    Business
    Yahoo Finance

    Apple Q1 earnings will put its China rebound in focus

    Apple is set to announce its Q1 2020 earnings results on Tuesday, giving investors and analysts their first solid look at the company's performance during the crucial holiday sales period, as well as a better understanding of how well the iPhone 11 has sold in its first few months of availability. The large year-over-year jump in expected revenue is a result of improved sales in China, which saw a significant slowdown for Apple in 2019, prompting CEO Tim Cook to issue a rare guidance revision ahead of the company's Q1 2019 earnings report. Importantly, analysts increasingly believe iPhone 11 sales outperformed their previous estimates, which may have helped Apple beat expectations in the quarter.